Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia
Clinical trial NCT06949852 · COMPLETED
Trial details
- NCT number
- NCT06949852
- Sponsor
- Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-07
- Primary completion
- 2025-07-08
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.